Koyuan Pharmaceutical: Shareholders holding more than 5% of the total shares reduce their holdings by 1,082,900 shares, and the reduction plan is completed.

Kexing Pharmaceutical announced that shareholders Jinan Caixin Science and Technology Investment Co., Ltd. and concerted action persons Jinan Caixin Investment Co., Ltd. and Jinan Municipal Finance Investment Fund Holding Group Co., Ltd., collectively holding more than 5% of the company's shares, cumulatively reduced their holdings of the company's shares by 1.0829 million shares through centralized competitive bidding from May 22 to May 25, 2026, accounting for 1.00% of the total share capital of the company. After the reduction, the total shareholding ratio decreased from 11.03% to 10.03%, and the equity change touched the integer multiple of 1%. The reduction plan has been implemented and completed. This reduction will not lead to a change in the company's control, and will not affect the company's ongoing operation.